Roles for Cbl and ESCRT Proteins in 5-HT Receptor Function

Cbl 和 ESCRT 蛋白在 5-HT 受体功能中的作用

基本信息

  • 批准号:
    7684371
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary/Abstract The objective of this proposal is to unravel novel molecular mechanisms of regulation of serotonin (5-HT) receptors, which are cell surface proteins that transduce extracellular signals into intracellular signals. 5-HT receptors are prototypical G protein-coupled receptors (GPCRs), constitute a significant portion of the human genome. They participate in nearly every aspect of physiology and in many disease states. Nevertheless, our understanding of how these receptors transfer signals remains incomplete. In particular, many aspects of their intracellular trafficking, and the specific proteins involved in determining the fate of GPCRs, remain mysterious. This will be accomplished using the following methodologies: confocal microscopy, subcellular fractionation, biochemical methods, fusion proteins and transfections into -- or silencing of genes expressed in -- Hek293 cells. The hypothesis upon which this work is based is that two key protein families known to be involved in degradation of growth factor receptors - Cbl and HRS - are critical mediators of recycling of 5-HT2A receptors. The first aim focuses on c-Cbl, and the second on HRS. The work is significant in that our preliminary data demonstrate unexpected roles for c-Cbl and HRS in recycling (rather than degradation) of 5-HT2A receptors. The work is clinically relevant in that 5-HT regulates mood, aggression, anxiety, sexual behavior, sleep-wakefulness, vascular tone, immune function, cell growth and proliferation, and fluid and electrolyte homeostasis. This work is particularly germane to the Veteran population in that those disorders are frequently encountered in VA clinical settings. Importantly, the incidence and severity of many of those maladies will worsen as our Veteran population continues to age. The topic of this proposal also is significant because of the fundamental importance of understanding GPCR signal transduction as it relates to all functions of human cells. GPCRs comprise the largest known family of integral membrane receptor proteins. GPCRs represent key therapeutic targets for the treatment of many diseases of Veterans including hypertension, atherosclerosis, stroke, heart failure, cancer, asthma, renal diseases, diabetes mellitus, traumatic brain injury, psychiatric diseases, neurodegenerative diseases, and immune disorders including AIDS. Ultimately, the type of fundamental research proposed in this application will likely lead to new therapeutic insights and strategies that will form the basis for clinical interventions in multiple disease states. PUBLIC HEALTH RELEVANCE: Relevance of the Research to the VA Patient Care Mission The work covered in this proposal is relevant to the VA patient care mission in two respects. First, it will add to our knowledge about how 5-HT regulates mood, aggression, anxiety, sexual behavior, sleep-wakefulness, vascular tone, immune function, cell growth and proliferation, and fluid and electrolyte homeostasis. This work is particularly germane to the Veteran population in that anxiety, sleep disorders, depression, vascular headache, atherosclerotic-thrombotic vascular diseases and hypertension are frequently encountered in VA clinical settings. Importantly, the incidence and severity of many of those maladies will worsen as our Veteran population continues to age. The second reason why the topic of this proposal is significant involves the fundamental importance of understanding GPCR signal transduction as it relates to all functions of human cells. GPCRs comprise the largest known family of integral membrane receptor proteins. Recent estimates suggest that the GPCRs represent H1,000 members, and the GPCR family makes up > 1% of the human genome. GPCRs respond to a wide variety of stimuli including hormones, neurotransmitters, light, odor, taste, and peptides. Consequently, they play critical roles in the regulation of all organ systems and hormonal functions. The central importance of GPCRs in human physiology and diseases is highlighted by the fact that more than half of all medications prescribed today are targeted at GPCRs. GPCRs represent key therapeutic targets for the treatment of many diseases of Veterans including hypertension, atherosclerosis, stroke, heart failure, cancer, asthma, renal diseases, diabetes mellitus, psychiatric diseases, neurodegenerative diseases, and immune disorders including AIDS. Ultimately, the type of fundamental research proposed in this application will likely lead to new therapeutic insights and strategies that will form the basis for clinical interventions in multiple disease states.
描述(由申请人提供): 项目概要/摘要本提案的目的是揭示5-羟色胺(5-HT)受体调节的新分子机制,5-HT受体是将细胞外信号转换为细胞内信号的细胞表面蛋白质。5-HT受体是典型的G蛋白偶联受体(GPCR),构成人类基因组的重要部分。它们几乎参与生理学的各个方面和许多疾病状态。然而,我们对这些受体如何传递信号的理解仍然不完整。特别是,它们的细胞内运输的许多方面,以及参与决定GPCR命运的特定蛋白质,仍然是神秘的。这将使用以下方法完成:共聚焦显微镜、亚细胞分级分离、生物化学方法、融合蛋白和转染到Hek 293细胞中或沉默Hek 293细胞中表达的基因。这项工作所基于的假设是,已知参与生长因子受体降解的两个关键蛋白质家族- Cbl和HRS -是5-HT 2A受体再循环的关键介质。第一个目标集中在c-Cbl,第二个目标集中在HRS。这项工作是重要的,因为我们的初步数据表明c-Cbl和HRS在5-HT 2A受体的再循环(而不是降解)中具有意想不到的作用。这项工作与临床相关,因为5-HT调节情绪、攻击性、焦虑、性行为、睡眠-觉醒、血管张力、免疫功能、细胞生长和增殖以及液体和电解质稳态。这项工作是特别密切相关的退伍军人群体,这些疾病经常遇到的VA临床设置。重要的是,随着我们的退伍军人人口继续老龄化,许多这些疾病的发病率和严重程度将恶化。该提案的主题也很重要,因为理解GPCR信号转导的根本重要性,因为它涉及人类细胞的所有功能。GPCR包含已知最大的整合膜受体蛋白家族。GPCR代表用于治疗退伍军人的许多疾病的关键治疗靶标,所述疾病包括高血压、动脉粥样硬化、中风、心力衰竭、癌症、哮喘、肾病、糖尿病、创伤性脑损伤、精神疾病、神经变性疾病和免疫病症(包括AIDS)。最终,本申请中提出的基础研究类型可能会导致新的治疗见解和策略,这些见解和策略将成为多种疾病状态下临床干预的基础。 公共卫生相关性: 研究与VA患者护理使命的相关性本提案中涵盖的工作在两个方面与VA患者护理使命相关。首先,它将增加我们对5-HT如何调节情绪、攻击性、焦虑、性行为、睡眠-觉醒、血管张力、免疫功能、细胞生长和增殖以及液体和电解质稳态的认识。这项工作是特别密切的退伍军人人群中,焦虑,睡眠障碍,抑郁症,血管性头痛,动脉粥样硬化血栓性血管疾病和高血压经常遇到的VA临床设置。重要的是,随着我们的退伍军人人口继续老龄化,许多这些疾病的发病率和严重程度将恶化。本提案主题重要的第二个原因涉及理解GPCR信号转导的根本重要性,因为它涉及人类细胞的所有功能。GPCR包含已知最大的整合膜受体蛋白家族。最近的估计表明,GPCR代表H1,000成员,GPCR家族占人类基因组的1%以上。GPCR对各种各样的刺激做出反应,包括激素、神经递质、光、气味、味觉和肽。因此,它们在所有器官系统和激素功能的调节中发挥关键作用。GPCR在人类生理学和疾病中的核心重要性突出表现在以下事实:今天处方的所有药物中有一半以上是针对GPCR的。GPCR代表用于治疗退伍军人的许多疾病的关键治疗靶标,所述疾病包括高血压、动脉粥样硬化、中风、心力衰竭、癌症、哮喘、肾脏疾病、糖尿病、精神疾病、神经变性疾病和免疫病症(包括AIDS)。最终,本申请中提出的基础研究类型可能会导致新的治疗见解和策略,这些见解和策略将成为多种疾病状态下临床干预的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John R Raymond其他文献

John R Raymond的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John R Raymond', 18)}}的其他基金

Mechanisms of Regulation of NHE-1
NHE-1的调节机制
  • 批准号:
    8147925
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Mechanisms of Regulation of NHE-1
NHE-1的调节机制
  • 批准号:
    7903712
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Roles for Cbl and ESCRT Proteins in 5-HT Receptor Function
Cbl 和 ESCRT 蛋白在 5-HT 受体功能中的作用
  • 批准号:
    7783783
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION
校外研究设施建设
  • 批准号:
    6706109
  • 财政年份:
    2003
  • 资助金额:
    --
  • 项目类别:
EXTRAMURAL RESEARCH FACILITIEIS CONSTRUCTION
校外研究设施建设
  • 批准号:
    6361124
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
Human Subjects Research Enhancements Program at MUSC
MUSC 人类受试者研究增强计划
  • 批准号:
    6779697
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
Human Subjects Research Enhancements Program at MUSC
MUSC 人类受试者研究增强计划
  • 批准号:
    6591528
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
Regulation of EGF Receptors by G protein receptor
G蛋白受体对EGF受体的调节
  • 批准号:
    6368869
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
Regulation of EGF Receptors by G protein receptor
G蛋白受体对EGF受体的调节
  • 批准号:
    6526032
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
Regulation of EGF Receptors by G protein receptor
G蛋白受体对EGF受体的调节
  • 批准号:
    6785962
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了